We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$6.87B
AUM Growth
+$918M
Cap. Flow
+$404M
Cap. Flow %
5.88%
Top 10 Hldgs %
30.67%
Holding
79
New
4
Increased
35
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$186M
2
AA icon
Alcoa
AA
+$148M
3
PPO
POLYPORE INTERNATIONAL, INC
PPO
+$130M
4
CTXS
Citrix Systems Inc
CTXS
+$104M
5
FTI icon
TechnipFMC
FTI
+$87.3M

Top Sells

Rank Stock Value
1
MOLXA
MOLEX INC CL-A
MOLXA
+$93.4M
2
MOLX
MOLEX INC
MOLX
+$90.6M
3
BSX icon
Boston Scientific
BSX
+$74M
4
BLC
BELO CORP SER A
BLC
+$57.9M
5
LUV icon
Southwest Airlines
LUV
+$50.2M

Sector Composition

Rank Sector Weight
1 Technology 29.22%
2 Industrials 16.12%
3 Healthcare 10.99%
4 Communication Services 9.03%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNPR
1
DELISTED
Juniper Networks
JNPR
$255M 3.71%
11,291,852
+2,291,977
+25% +$46.5M
AKAM icon
2
Akamai
AKAM
$15.6B
$223M 3.25%
4,736,873
+1,305,216
+38% +$61.6M
NYT icon
3
New York Times
NYT
$12.6B
$221M 3.22%
13,931,397
-1,085,275
-7% -$14.8M
FTI icon
4
TechnipFMC
FTI
$28.6B
$208M 3.02%
5,344,499
+2,249,036
+73% +$87.3M
CVSA
5
Covista Inc
CVSA
$4.55B
$206M 3%
5,803,794
-764,089
-12% -$26.4M
XYL icon
6
Xylem
XYL
$28.5B
$204M 2.97%
5,894,956
-321,746
-5% -$10.3M
EW icon
7
Edwards Lifesciences
EW
$49.4B
$201M 2.93%
18,350,790
+16,485,390
+884% +$186M
HSP
8
DELISTED
HOSPIRA INC
HSP
$201M 2.93%
4,867,505
-559,838
-10% -$22.5M
CTXS
9
DELISTED
Citrix Systems Inc
CTXS
$195M 2.83%
3,864,023
+2,188,914
+131% +$104M
SPLS
10
DELISTED
Staples Inc
SPLS
$193M 2.82%
12,170,791
+618,500
+5% +$9.64M
NUAN
11
DELISTED
Nuance Communications, Inc.
NUAN
$182M 2.66%
13,860,286
+2,656,630
+24% +$36.5M
VAR
12
DELISTED
Varian Medical Systems, Inc.
VAR
$181M 2.64%
2,657,861
+422,186
+19% +$28.1M
ITRI icon
13
Itron
ITRI
$4.54B
$180M 2.62%
4,343,310
+125,669
+3% +$5.33M
AGCO icon
14
AGCO
AGCO
$8.41B
$176M 2.56%
2,972,108
+951,644
+47% +$56.7M
AA icon
15
Alcoa
AA
$11.3B
$170M 2.48%
+6,662,124
New +$148M
JBL icon
16
Jabil
JBL
$30.1B
$169M 2.47%
9,710,413
+2,470,693
+34% +$50.1M
IPG
17
DELISTED
Interpublic Group of Companies
IPG
$164M 2.39%
9,265,920
+328,174
+4% +$5.53M
NVDA icon
18
NVIDIA
NVDA
$4.6T
$164M 2.38%
408,270,520
+672,960
+0.2% +$261K
RJF icon
19
Raymond James Financial
RJF
$33.5B
$162M 2.36%
4,663,850
+1,015,874
+28% +$31.5M
PPO
20
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$157M 2.29%
4,038,630
+3,304,536
+450% +$130M
WOLF icon
21
Wolfspeed
WOLF
$1.04B
$156M 2.27%
2,491,757
+361,620
+17% +$22.3M
UIS icon
22
Unisys
UIS
$252M
$153M 2.23%
4,567,779
-419,776
-8% -$11.6M
MDR
23
DELISTED
McDermott International
MDR
$141M 2.06%
5,142,711
-1,359,691
-21% -$31.8M
WERN icon
24
Werner Enterprises
WERN
$2.2B
$136M 1.98%
5,512,555
+94,497
+2% +$2.24M
NTRS icon
25
Northern Trust
NTRS
$21.8B
$136M 1.98%
2,195,744
+19,733
+0.9% +$1.13M
1
2 3 4

Similar funds

EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
CIA
CSat Investment Advisory Detroit, Michigan $119M AUM 77.51% 1-Year Est. Return
FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return

Fairpointe Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Fairpointe Capital held 79 positions worth $6.87B, up 15% from $5.95B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fairpointe Capital deployed $404M of net new capital in Q4 2013, opening 4 new positions and adding to 35 existing holdings. Its largest new stake was Alcoa: 6,662,124 shares worth $170M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Boston Scientific, an estimated $74M trimmed.

  • Fairpointe Capital's largest Q4 2013 buy was Alcoa: 6,662,124 shares worth $170M.
  • Fairpointe Capital added most to Edwards Lifesciences in Q4 2013, an estimated $186M increase.
  • Fairpointe Capital's biggest Q4 2013 reduction was Boston Scientific, cutting an estimated $74M.
  • Fairpointe Capital fully exited MOLEX INC CL-A in Q4 2013, selling an estimated $93.4M.
  • Fairpointe Capital's ten largest holdings make up 31% of its $6.87B portfolio in Q4 2013.
  • Fairpointe Capital opened 4 new positions and closed 3 in Q4 2013.
  • Fairpointe Capital's portfolio value rose 15% quarter-over-quarter to $6.87B.

Based on Fairpointe Capital's 13F filing for Q4 2013, filed 11 Feb 2014.